DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Midodrine Hydrochloride is a drug marketed by Alembic Pharms Ltd, Apotex, Aurobindo Pharma Ltd, Chartwell Rx, Impax Pharms, Mylan Pharms Inc, Par Pharm Inc, Rubicon, Unique Pharm Labs, Xiromed, and Zydus. and is included in eleven NDAs.
The generic ingredient in MIDODRINE HYDROCHLORIDE is midodrine hydrochloride. There are thirteen drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the midodrine hydrochloride profile page.
A generic version of MIDODRINE HYDROCHLORIDE was approved as midodrine hydrochloride by MYLAN PHARMS INC on September 10th, 2003.
Recent Clinical Trials for MIDODRINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Vanderbilt University Medical Center||N/A|
|Vanderbilt University Medical Center||Early Phase 1|
|AJA University of Medical Sciences||Phase 3|